Description
Rosuvis F Forte combines Rosuvastatin and Fenofibrate to manage lipid disorders, especially in patients with mixed dyslipidemia and high triglycerides. Each tablet delivers 10 mg of Rosuvastatin and 160 mg of Fenofibrate for dual-action cholesterol control.
This combination is prescribed to lower LDL (bad cholesterol) and triglycerides, while increasing HDL (good cholesterol). Rosuvastatin inhibits cholesterol synthesis in the liver, and Fenofibrate promotes the breakdown of triglycerides. It’s especially effective for patients at risk of cardiovascular disease due to abnormal lipid profiles. Rosuvis F Forte is typically taken once daily, with or without food, under the guidance of a healthcare professional. Regular monitoring of liver function and lipid levels is recommended during treatment. This medication is part of a long-term strategy to reduce heart disease risk when combined with lifestyle changes such as diet and exercise.
